Spontaneous Complete Resolution of Alopecia Totalis Post SARS-CoV-2 Infection

August 2022 in “ JAAD Case Reports ”

Georgio Chidiac, Remie Chrabieh, Micheline Maamari, Jinane El Khoury, N. Ayoub

alopecia totalis hair regrowth autoimmune reaction hair follicles SARS-CoV-2 infection AT COVID-19

Studysummary A woman's complete hair loss condition improved after recovering from COVID-19.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jaadcasereports.org →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Tofacitinib Treatment in Patients With Active COVID-19 Infection

2 citations , September 2021 in “Curēus”

In this study, two patients with alopecia universalis continued using tofacitinib during active COVID-19 infection and showed no worsening of their illness, despite potential concerns about immunosuppression.

research Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients

11 citations , May 2021 in “Journal of The American Academy of Dermatology”

This study found that mild-to-moderate COVID-19 was not associated with worsening in patients with pre-existing alopecia areata.

research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations

32 citations , March 2021 in “Journal of cosmetic dermatology (Print)”

This letter to the editor discusses a potential link between new onset alopecia areata and SARS-CoV-2 infection, but reports no new clinical results.

research Alopecia Areata: A Comprehensive Review of Pathogenesis and Management

99 citations , July 2017 in “Clinical Reviews in Allergy & Immunology”

This review noted that alopecia areata is an autoimmune disease impacting hair follicles and offered insights into its complex pathogenesis involving immune responses, while highlighting ongoing research into new treatments such as Janus kinase inhibitors and other immunomodulatory drugs.